Related Experiment Video
Updated: May 24, 2026

09:29
Electrospinning Growth Factor Releasing Microspheres into Fibrous Scaffolds
Published on: August 16, 2014
Electrospun matrices for localized drug delivery: current technologies and selected biomedical applications
Anne J Meinel1, Oliver Germershaus, Tessa Luhmann
1Institute of Pharmaceutical Sciences, ETH Zurich, Zurich, Switzerland. l.meinel@pharmazie.uni-wuerzburg.de
Summary
Electrospun scaffolds offer versatile drug delivery systems for various therapeutics. While adaptable, translating these advanced fibrous matrices into clinical applications remains a challenge.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Drug Delivery Systems
Background:
- Electrospinning fabricates nano- to micrometer-sized fibrous matrices using diverse materials and techniques.
- Post-spinning modifications enhance the versatility of these matrices for tailored applications.
- Electrospun scaffolds are increasingly explored for advanced drug delivery functionalities.
Purpose of the Study:
- To provide an overview of current developments in manufacturing electrospun matrices for drug delivery.
- To discuss efficient drug loading and release strategies within these matrices.
- To highlight biomedical applications and future prospects of electrospun drug delivery systems.
Main Methods:
- Overview of electrospinning fabrication techniques for matrix production.
- Discussion of post-spinning modification strategies for enhanced functionality.
- Analysis of drug loading and release mechanisms for various therapeutic agents.
Main Results:
- Electrospun matrices can incorporate a wide range of drugs, including small molecules, proteins, nucleic acids, and mRNA.
- Diverse biomedical applications show promising results, leveraging the combined features of fibrous structures and drug delivery.
- Significant variation is possible in scaffold material, spatial design, and surface modification.
Conclusions:
- Electrospun scaffolds are highly versatile for incorporating various drugs, offering substantial design flexibility.
- The wide array of parameters in development may hinder clinical translation.
- Further research is needed to bridge the gap between concept development and therapeutic reality.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Modified-Release Drug Delivery Systems: Rate-Programmed II
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...

